A detailed history of D. E. Shaw & Co., Inc. transactions in Agilent Technologies, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 13,464 shares of A stock, worth $1.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,464
Holding current value
$1.8 Million
% of portfolio
0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$125.42 - $148.48 $1.15 Million - $1.36 Million
9,146 Added 211.81%
13,464 $2 Million
Q2 2024

Aug 14, 2024

SELL
$129.63 - $154.64 $3.67 Million - $4.38 Million
-28,346 Reduced 86.78%
4,318 $559,000
Q1 2024

May 15, 2024

SELL
$128.12 - $149.31 $18 Million - $21 Million
-140,739 Reduced 81.16%
32,664 $4.75 Million
Q4 2023

Feb 14, 2024

SELL
$101.17 - $139.82 $84.3 Million - $117 Million
-833,378 Reduced 82.78%
173,403 $24.1 Million
Q3 2023

Nov 14, 2023

SELL
$109.73 - $128.47 $1.73 Million - $2.03 Million
-15,787 Reduced 1.54%
1,006,781 $113 Million
Q2 2023

Aug 14, 2023

BUY
$114.69 - $141.28 $13.5 Million - $16.6 Million
117,481 Added 12.98%
1,022,568 $123 Million
Q1 2023

May 15, 2023

BUY
$131.13 - $159.06 $12.9 Million - $15.6 Million
98,254 Added 12.18%
905,087 $125 Million
Q4 2022

Feb 14, 2023

SELL
$125.64 - $157.68 $45.8 Million - $57.4 Million
-364,283 Reduced 31.11%
806,833 $121 Million
Q3 2022

Nov 14, 2022

SELL
$115.11 - $142.29 $61.6 Million - $76.1 Million
-534,707 Reduced 31.35%
1,171,116 $142 Million
Q2 2022

Aug 15, 2022

SELL
$112.71 - $135.93 $20.3 Million - $24.5 Million
-180,202 Reduced 9.55%
1,705,823 $203 Million
Q1 2022

May 16, 2022

BUY
$126.0 - $156.48 $74 Million - $91.9 Million
586,980 Added 45.19%
1,886,025 $250 Million
Q4 2021

Feb 14, 2022

SELL
$147.95 - $164.3 $44.2 Million - $49.1 Million
-298,583 Reduced 18.69%
1,299,045 $207 Million
Q3 2021

Nov 15, 2021

BUY
$147.58 - $179.28 $92.2 Million - $112 Million
624,756 Added 64.22%
1,597,628 $252 Million
Q2 2021

Aug 16, 2021

SELL
$127.69 - $148.81 $8.82 Million - $10.3 Million
-69,069 Reduced 6.63%
972,872 $144 Million
Q1 2021

May 17, 2021

SELL
$114.99 - $130.12 $71.4 Million - $80.8 Million
-620,971 Reduced 37.34%
1,041,941 $132 Million
Q4 2020

Feb 16, 2021

SELL
$100.01 - $119.3 $95 Million - $113 Million
-949,867 Reduced 36.35%
1,662,912 $197 Million
Q3 2020

Nov 16, 2020

SELL
$88.11 - $103.42 $73.8 Million - $86.7 Million
-838,003 Reduced 24.28%
2,612,779 $264 Million
Q2 2020

Aug 14, 2020

SELL
$68.92 - $91.14 $99.3 Million - $131 Million
-1,440,379 Reduced 29.45%
3,450,782 $305 Million
Q1 2020

May 15, 2020

SELL
$63.37 - $90.13 $7.41 Million - $10.5 Million
-116,874 Reduced 2.33%
4,891,161 $350 Million
Q4 2019

Feb 14, 2020

SELL
$72.49 - $85.45 $2.45 Million - $2.89 Million
-33,831 Reduced 0.67%
5,008,035 $427 Million
Q3 2019

Nov 14, 2019

BUY
$65.59 - $78.07 $8.6 Million - $10.2 Million
131,071 Added 2.67%
5,041,866 $386 Million
Q2 2019

Aug 14, 2019

BUY
$66.89 - $81.94 $95.2 Million - $117 Million
1,423,567 Added 40.82%
4,910,795 $367 Million
Q1 2019

May 15, 2019

BUY
$63.27 - $82.0 $48,021 - $62,238
759 Added 0.02%
3,487,228 $280 Million
Q4 2018

Feb 14, 2019

SELL
$61.13 - $74.67 $95.2 Million - $116 Million
-1,557,005 Reduced 30.87%
3,486,469 $235 Million
Q3 2018

Nov 14, 2018

SELL
$61.25 - $71.13 $60 Million - $69.7 Million
-980,224 Reduced 16.27%
5,043,474 $356 Million
Q2 2018

Aug 14, 2018

BUY
$61.14 - $69.55 $80.9 Million - $92 Million
1,322,889 Added 28.14%
6,023,698 $373 Million
Q1 2018

May 15, 2018

BUY
$65.05 - $74.82 $56 Million - $64.5 Million
861,461 Added 22.44%
4,700,809 $314 Million
Q4 2017

Feb 14, 2018

SELL
$64.87 - $70.59 $4.68 Million - $5.1 Million
-72,203 Reduced 1.85%
3,839,348 $257 Million
Q3 2017

Nov 14, 2017

BUY
$58.57 - $66.17 $229 Million - $259 Million
3,911,551
3,911,551 $251 Million

Others Institutions Holding A

About AGILENT TECHNOLOGIES, INC.


  • Ticker A
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 296,040,992
  • Market Cap $39.6B
  • Description
  • Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatogra...
More about A
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.